Successful salvage of a relapsed high risk gestational trophoblastic neoplasia patient using capecitabine
Author:
Publisher
Elsevier BV
Subject
Obstetrics and Gynecology,Oncology
Reference10 articles.
1. Effect of methotrexate therapy upon choriocarcinoma and chorioadenoma;Hertz;Proc. Soc. Exp. Biol. Med.,1956
2. Results with the EMA/CO (etoposide, methotrexate, actinomycin D, cyclophosphamide, vincristine) regimen in high risk gestational trophoblastic tumours, 1979 to 1989;Newlands;Br. J. Obstet. Gynaecol.,1991
3. Combining the staging system of the International Federation of Gynecology and Obstetrics with the scoring system of the World Heath Organization for Trophoblastic Neoplasia. Report of the Working Committee of the International Society for the Study of Trophoblastic Disease and the International Gynecologic Cancer Society
4. Trophoblastic disease;Kavanagh,2003
5. Results and toxicity using PE/EMA schedule in patients with gestational trophoblastic tumors;Newlands;ASCO Proc.,2001
Cited by 13 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Single-Agent Capecitabine: A Safe and Effective Option in Refractory Gestational Trophoblastic Neoplasia;Indian Journal of Gynecologic Oncology;2024-09-11
2. A Phase II Basket Trial of Dual Anti–CTLA-4 and Anti–PD-1 Blockade in Rare Tumors (DART SWOG 1609 Cohort 47) in Patients with Gestational Trophoblastic Neoplasia;Clinical Cancer Research;2023-10-26
3. Gestational trophoblastic disease;Comprehensive Gynecology;2022
4. Successful salvage treatment with paclitaxel, ifosfamide, and cisplatin in a patient with methotrexate‐resistant gestational trophoblastic neoplasia who developed hypersensitivity reaction to etoposide;Journal of Obstetrics and Gynaecology Research;2021-07-18
5. Treatment of high-risk gestational trophoblastic neoplasia and chemoresistance/relapsed disease;Best Practice & Research Clinical Obstetrics & Gynaecology;2021-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3